美国俄亥俄州新冠疫情后儿童中的大环内酯类耐药肺炎支原体感染
Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.
作者信息
Leber Amy L, Embry Tori, Everhart Kathy, Taveras Jeanette, Oyeniran Sophonie J, Wang Huanyu
出版信息
Emerg Infect Dis. 2025 Mar;31(3):555-558. doi: 10.3201/eid3103.241570.
Abstract
Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023--September 2024. Of 995 M. pneumoniae-positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are low but increasing. MRMp surveillance is crucial for monitoring antimicrobial resistance.
摘要
在美国俄亥俄州，肺炎支原体感染在新冠疫情期间有所减少，但在2023年再次出现；2023年9月至2024年9月期间报告了2000多例病例。在995份肺炎支原体阳性样本中，有24份（2.4%）存在大环内酯耐药肺炎支原体（MRMp）的突变。MRMp的发生率较低但呈上升趋势。MRMp监测对于监测抗菌药物耐药性至关重要。
Zotero 插件